ahlam1399
03-29-2016, 01:33 AM
BRIEF-Fennec Pharmaceuticals qtrly loss per share $0.05
* Fennec provides corporate update and an**unces fiscal year ended december 31, 2015 financial results
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e9007d7/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=CoUFOT1cxoU:6yz7t5SZnC0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=CoUFOT1cxoU:6yz7t5SZnC0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=CoUFOT1cxoU:6yz7t5SZnC0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=CoUFOT1cxoU:6yz7t5SZnC0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=CoUFOT1cxoU:6yz7t5SZnC0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/CoUFOT1cxoU
* Fennec provides corporate update and an**unces fiscal year ended december 31, 2015 financial results
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e9007d7/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=CoUFOT1cxoU:6yz7t5SZnC0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=CoUFOT1cxoU:6yz7t5SZnC0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=CoUFOT1cxoU:6yz7t5SZnC0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=CoUFOT1cxoU:6yz7t5SZnC0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=CoUFOT1cxoU:6yz7t5SZnC0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/CoUFOT1cxoU